Deflin Gayle 4
4 · Amphastar Pharmaceuticals, Inc. · Filed Jun 7, 2023
Insider Transaction Report
Form 4
Deflin Gayle
Director
Transactions
- Award
Common Stock
2023-06-05+2,716→ 6,879 total - Award
Stock Option (right to buy)
2023-06-05+7,016→ 7,016 totalExercise: $46.01Exp: 2031-06-05→ Common Stock (7,016 underlying)
Footnotes (2)
- [F1]The reported shares are represented by restricted stock units, or RSUs, all of which vest on June 5, 2024.
- [F2]All of the shares subject to the option vest on June 5, 2024.